» Articles » PMID: 35163734

The Human Microbiota and Skin Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163734
Authors
Affiliations
Soon will be listed here.
Abstract

Skin cancer is the most common type of cancer in the US with an increasing prevalence worldwide. While ultraviolet (UV) radiation is a well-known risk factor, there is emerging evidence that the microbiota may also contribute. In recent years, the human microbiota has become a topic of great interest, and its association with inflammatory skin diseases (i.e., atopic dermatitis, acne, rosacea) has been explored. Little is known of the role of microbiota in skin cancer, but with the recognized link between microbial dysbiosis and inflammation, and knowledge that microbiota modulates the effect of UV-induced immunosuppression, theories connecting the two have surfaced. In this paper, we provide a comprehensive review of the key literature on human microbiota, especially the skin microbiota, and skin cancer (i.e., non-melanoma skin cancer, melanoma, cutaneous T cell lymphoma). Also, mechanistic perspectives as to how our microbiota influence skin cancer development and treatment are offered.

Citing Articles

The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage.

Lorphelin J, Dompmartin A, Dreno B Pigment Cell Melanoma Res. 2025; 38(2):e13224.

PMID: 40016867 PMC: 11868406. DOI: 10.1111/pcmr.13224.


Synthesis, Antimicrobial Activity, and Tyrosinase Inhibition by Multifunctional 3,4-Dihydroxy-Phenyl Peptidomimetics.

Wavhal D, Koszelewski D, Kowalczyk P, Brodzka A, Ostaszewski R Int J Mol Sci. 2025; 26(4).

PMID: 40004165 PMC: 11855086. DOI: 10.3390/ijms26041702.


The interplay between gut bacteria and targeted therapies: implications for future cancer treatments.

He J, Chen Y, Zhao H, Li Y Mol Med. 2025; 31(1):58.

PMID: 39948481 PMC: 11827328. DOI: 10.1186/s10020-025-01108-6.


Unveiling the hidden causal links: skin flora and cutaneous melanoma.

Zhang Z, Wu W, Lin J, Li H Front Oncol. 2024; 14:1451175.

PMID: 39723372 PMC: 11668787. DOI: 10.3389/fonc.2024.1451175.


Recent global patterns in skin cancer incidence, mortality, and prevalence.

Wang M, Gao X, Zhang L Chin Med J (Engl). 2024; 138(2):185-192.

PMID: 39682020 PMC: 11745855. DOI: 10.1097/CM9.0000000000003416.


References
1.
Iannitti T, Palmieri B . Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010; 29(6):701-25. PMC: 7172412. DOI: 10.1016/j.clnu.2010.05.004. View

2.
Sherwani M, Tufail S, Muzaffar A, Yusuf N . The skin microbiome and immune system: Potential target for chemoprevention?. Photodermatol Photoimmunol Photomed. 2017; 34(1):25-34. PMC: 7289174. DOI: 10.1111/phpp.12334. View

3.
Safai B, Myskowski P, DuPont B, Pollack M . Association of HLA-DR5 with mycosis fungoides. J Invest Dermatol. 1983; 80(5):395-7. DOI: 10.1111/1523-1747.ep12553615. View

4.
Ganzenmueller T, Yakushko Y, Kluba J, Henke-Gendo C, Gutzmer R, Schulz T . Next-generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma. Int J Cancer. 2012; 131(7):E1173-9. DOI: 10.1002/ijc.27581. View

5.
Clarke G, Stilling R, Kennedy P, Stanton C, Cryan J, Dinan T . Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28(8):1221-38. PMC: 5414803. DOI: 10.1210/me.2014-1108. View